Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Rudy Saucillo who wrote (1212)	6/24/1998 12:27:00 PM
From: Steve Harmon	Respond to of 2742

Rudy, You are right on the Genzyme deal Richard pointed out yesterday. Normally that would have done wonders for Cistron since the technology sold was similiar to Cist's. There was a lot of buying yesterday but Cist's stock barely budged. Bluestone Capital gave NO stock support...A little stock support would have pushed our shares higher giving IL-1 a bit of a premium above cash level. The way the Bluestone Capital deal is set up it is destroying our stock price. They don't want it to go up until the price on the remaining 400,000 warrants is set! Bruce Galton>>>Put a set price on the remaining warrants...so then shareholder assets can reach their proper values.